China Health Group (HKSE:00673) GF Score: 24/100 (As of Aug. 12, 2026) — 44% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00673 China Health Group Ltd HKSE:00673
24 GF Score
Price HK$0.40
GF Value HK$0.24
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is China Health Group GF Score?

China Health Group HKSE:00673 24 GF Score is 24 as of Aug. 12, 2026, which is 44% below its 10-year median of 43.00. GuruFocus rates HKSE:00673 with a GF Score™ of 24/100 and a GF Value™ of HK$0.24 (Significantly Overvalued). The stock has 6 warning signs investors should review.

China Health Group has the GF Score of 24, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 5/10
2. Profitability Rank : 1/10
3. Growth Rank : 1/10
4. GF Value Rank : 3/10
5. Momentum Rank : 2/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes China Health Group might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

China Health Group  (HKSE:00673) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

China Health Group GF Score Related Terms

HKSE:00673 vs MCK, COR, CAH: GF Score Comparison

For the Medical Distribution subindustry, China Health Group's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Health Group GF Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China Health Group's GF Score distribution charts can be found below:

* The bar in red indicates where China Health Group's GF Score falls into.


HKSE:00673
24GF Score
China Health Group Ltd HKSE:00673
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 24 mean?
China Health Group (HKSE:00673) has a GF Score of 24 as of Aug. 12, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on China Health Group and its competitors. This is 44% below median its historical median of 43.00. Over the past decade, China Health Group's GF Score has ranged from 19.00 to 73.00.
Is China Health Group's GF Score too high?
China Health Group's current GF Score of 24 is 44% below median its 10-year median of 43.00. Over the past 10 years, this metric has ranged from a low of 19.00 to a high of 73.00. Overall, China Health Group has a GF Score™ of 24/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does China Health Group's GF Score compare to MCK and COR?
China Health Group's GF Score of 24 can be compared against companies in the Medical Distribution industry. Historically, China Health Group's own GF Score has ranged from 19.00 to 73.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Distribution company?
A good GF Score depends on the Medical Distribution industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on China Health Group and its competitors. China Health Group's current GF Score is 24, which is 44% below median its own 10-year median of 43.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Group stock overvalued right now?
Based on GuruFocus' analysis, China Health Group (HKSE:00673) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.24, compared to a current price of HK$0.40 — trading 66.7% above its estimated fair value. The current GF Score is 24, which is 44% below median its 10-year median of 43.00. China Health Group's overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For China Health Group (HKSE:00673), the current GF Score is 24 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Health Group (HKSE:00673) Overvalued in 2026?

Based on GuruFocus' analysis, China Health Group stock appears to be overvalued. The current stock price of HK$0.40 is trading 66.7% above its estimated GF Value™ of HK$0.24. GuruFocus considers China Health Group to be Significantly Overvalued.

Key valuation signals for HKSE:00673:

  • GF Score: 24 (44% below median its 10-year median of 43.00)
  • GF Value™: HK$0.24 vs. price of HK$0.40 (66.7% above fair value)
  • GF Score™: 24/100 with 6 warning signs

No single metric tells the full story. See the HKSE:00673 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Health Group Business Description

Address 141 Des Voeux Road, Unit 801, 8th Floor, China Insurance Group Building, Central, Hong Kong, HKG
China Health Group Ltd is an investment holding company. It is principally engaged in the distribution and service of medical equipment and consumables, provision of hospital operation and management services, and business factoring. It operates in the business in four segments: medical equipment and consumables distribution and service business; hospital operation and management services business; business service; and research and development and sale of functional food. It derives a majority of revenue from the Distribution and service in the medical equipment and consumables segment. Geographically, the group derives its revenue from the PRC.
24GF Score

Get the complete analysis for HKSE:00673

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.40
Price
HK$0.24
GF Value